Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:
Product sales		$ 50		$ 530
Total revenues		50		530
Cost of revenues:
Product sales		20		212
Total cost of revenues		20		212
Gross Margin		30		318
Operating expenses:
Research and development expenses	33,659	70,809	105,450	243,748
Selling, general and administrative expenses	50,793	60,826	302,581	191,614
Total operating expenses	84,452	131,635	408,031	435,362
Operating loss	(84,452)	(131,605)	(408,031)	(435,044)
Other income (expense)
Gain on debt conversion				15,220
Change in fair value of derivatives		15,096	4,217	37,750
Interest expense	(31,101)	(30,266)	(91,409)	(129,442)
Net loss	(115,553)	(146,775)	(495,223)	(511,516)
Preferred stock dividend	(8,097)	(8,097)	(24,293)	(22,753)
Net loss applicable to common shareholders	$ (123,650)	$ (154,872)	$ (519,516)	$ (534,269)
Basic and diluted net loss per share (in Dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Weighted average shares outstanding – basic and diluted (in Shares)	73,377,059	73,554,897	73,494,966	73,304,993